Hagens Berman Reminds Synergy Pharmaceuticals Investors of the April 10, 2018 Lead Plaintiff Deadline and Alerts them to the Expanded Class Period
March 07, 2018 16:00 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, March 07, 2018 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) investors to the expanded class period and the April 10, 2018...
Hagens Berman Reminds Synergy Pharmaceuticals Investors of the April 10, 2018 Lead Plaintiff Deadline in the Securities Class Action Linked to Loan Disclosures
February 28, 2018 09:30 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP reminds investors in Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) of the April 10, 2018 Lead Plaintiff deadline in the...
Hagens Berman Alerts Synergy Pharmaceuticals Investors to the Securities Class Action Concerning Loan Disclosures and to the April 10, 2018 Lead Plaintiff Deadline
February 14, 2018 16:16 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) to the securities class action pending in the United...